ResMed Inc. Common Stock (NYSE:RMD):
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2017.
In the market the company is trading up by 0.87 percent from yesterday’s close.
ResMed Inc. Common Stock also announced a dividend for shareholders which was paid on Thursday September 22nd, 2016. The dividend was $0.330 per share for the quarter which comes to $1.32 on an annualized basis. This dividend amount represented a yeild of $2.06. The ex-dividend date was Tuesday the 16th of August 2016.
Company shares last traded at $60.35 which is slightly below $63.95, the 50 day moving average and marginally under the 200 day moving average of $63.07. The 50 day moving average was down $-3.60 and the 200 day average moved down $-2.72.
ResMed Inc. Common Stock currently has a P/E ratio of 24.63 and market cap is 8.50B. In the last earnings report the EPS was $2.45 and is expected to be $2.77 for the current year with 140,785,000 shares now outstanding. Analysts expect next quarter’s EPS will be $0.71 and the next full year EPS is projected to be $3.06.
A few Wall Street investment firms have released opinions on RMD of late. On September 29 the company was rated “Buy” in a report from Bank of America which was a boost from the previous “” rating. On September 19 the stock rating was downgraded to “Neutral” from “Overweight” in a report from JP Morgan.
On August 23, 2016 the stock rating was set at “Underperform” according to a Jefferies report which is down from the previous “Hold” rating. On June 27 the company was downgraded from “Hold” to “Underperform” by Needham.
On April 28 the company was upgraded to “Neutral” from “Neutral” with a current price target of $57.00 in a statement from Macquarie. On April 27 the company was downgraded from “” to “Neutral” and a price target of $57.00 was set in an announcement from Piper Jaffray.